Navigation Links
Gaiam to Announce First Quarter 2009 Results
Date:5/1/2009

BOULDER, Colo., May 1 /PRNewswire-FirstCall/ -- Gaiam, Inc. (Nasdaq: GAIA), a lifestyle media company providing information, media, products and services to customers who value personal development, wellness, ecological lifestyles, responsible media and conscious community, will announce results for the first quarter ended March 31, 2009 at close of the market on Wednesday, May 6, 2009.

The Company will hold a teleconference to discuss these results with additional comments and details. Participating in the call will be Jirka Rysavy, Chairman, Lynn Powers, Chief Executive Officer & President, Vilia Valentine, Chief Financial Officer and Carole Buyers, VP Corporate Finance and Investor Relations.

The conference call is scheduled to begin at 2:30 p.m. MDT (4:30 p.m. EDT) on May 6, 2009. Participants may access the call by dialing (888) 946-2714 (domestic) or (312) 470-7365 (international), passcode GAIAM.

    Contacts: Carole Buyers
    VP Corporate Finance and Investor Relations
    303-222-3808
    carole.buyers@gaiam.com

    John Mills
    Senior Managing Director, ICR
    310-954-1105
    jmills@icrinc.com


'/>"/>
SOURCE Gaiam, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Gaiam to Announce Fourth Quarter 2008 and Year End Results
2. New Strong Knees DVD Offers Knee Pain Relief from Body Insight, Inc. and Gaiam Inc.
3. Gaiam Inc., The Leader in Innovative Lifestyle Solutions, Announces New DVD Series Created with Mayo Clinic
4. Healthy Living Network Announces Launch of New Supplement Information Web Site
5. Dr. David Williams Announces the Launch of a New Product--IFS Defense--for Help with Itchy Flaky Skin
6. IPitomy Announces Distribution Relationship With Target Distributing
7. Steinberg Announces Senate Select Committee on Autism and Related Disorders
8. Brookdale Announces First Quarter 2009 Release and Earnings Call
9. Omnicell Announces First Quarter 2009 Results
10. PhotoThera Closes $50 Million Financing, Announces New President and Chief Executive Officer
11. VGI Announces Expansion to Meet Surgeon Demand for the VerteLoc™ Spine Stabilization System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... 2017 , ... A Palm Beach doctor plans to run the 2017 London ... provides free surgery to poor children suffering from cleft lip and cleft palate. , ... to support the efforts of the American Heart Association and the Leukemia and Lymphoma ...
(Date:1/18/2017)... ... January 18, 2017 , ... Dr. Farhan Qureshi is an ... implants dentistry. His modern dental practice has two convenient office locations in Alexandria and ... Rated Dentist for the Alexandria area. This award confirms the fact that ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... gum disease to enamel erosion, and those dental problems can increase the risk ... Health, many pregnant women are failing to get the dental care they need. ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... of difference. Eden Activewear is a stand-out company for several differences from other ... and only manufacture on demand, this is called 'Agile' manufacturing - http://www.leanproduction.com/agile-manufacturing.html ...
(Date:1/17/2017)... St. Petersburg, Florida (PRWEB) , ... January 17, 2017 , ... ... and the Producers of AsSeenOnTV.pro will be featuring DRTV campaigns regarding the topic of ... year to become a better version of themselves. What better way to commit to ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Jan. 17, 2017 Paragon Bioservices received a ... development services for a variety of National ... medical product development activities. The IDIQ mechanism will ... for task order awards up to $159 million. ... manufacturing and process development of biopharmaceuticals, is one ...
(Date:1/17/2017)... Management to Discuss Acquisition of Oncology ... On Track For An NDA Submission to ...   ... KTOV ; TASE: KTOV), an innovative biopharmaceutical company, announced that it will ... Eastern Time to discuss the recent acquisition of a majority stake in TyrNovo, ...
(Date:1/17/2017)... DUBLIN , Jan. 17, 2017  Jazz Pharmaceuticals ... first patient has been enrolled in a Phase 3 ... versus best supportive care (BSC) in the prevention of ... undergoing hematopoietic stem cell transplant (HSCT) who are at ... VOD.  The defibrotide clinical trial will be conducted across ...
Breaking Medicine Technology: